IM Cannabis (IMCC) Long-Term Investments (2019 - 2024)
IM Cannabis (IMCC) posted quarterly Long-Term Investments of $1.7 million for Q3 2024, up 1.84% year-over-year from $1.6 million in Q4 2023, and little changed quarter-over-quarter from $1.7 million in Q2 2024.
IM Cannabis (IMCC) Long-Term Investments (2019 - 2024) Analysis & Trends
IM Cannabis' Long-Term Investments history runs 6 years deep, the most recent figure standing at $1.7 million for Q3 2024.
- In Q3 2024, Long-Term Investments rose 1.84% year-over-year to $1.7 million; the TTM figure through Sep 2024 stood at $1.7 million (up 1.84% YoY), while the FY2023 annual figure was $1.7 million, down 8.64% from the prior year.
- Long-Term Investments for Q3 2024 stood at $1.7 million, roughly flat from $1.7 million in the prior quarter.
- The five-year high for Long-Term Investments was $2.9 million in Q2 2021, with the low at $1.5 million in Q1 2024.
- The 5-year median for Long-Term Investments is $1.8 million (2022), against an average of $1.8 million.
- The sharpest annual moves came in 2020 and 2022: Long-Term Investments jumped 947.2% in 2020, then plunged 37.36% in 2022.
- IM Cannabis' Long-Term Investments stood at $1.8 million in 2020, then gained by 7.31% to $1.9 million in 2021, then decreased by 7.86% to $1.8 million in 2022, then retreated by 5.47% to $1.7 million in 2023, then retreated by 0.33% to $1.7 million in 2024.
- Business Quant data shows IMCC's Long-Term Investments at $1.7 million in Q3 2024, $1.7 million in Q2 2024, and $1.5 million in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | IM Cannabis | 549,631.99 | -619,338.18 | 1.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 1.67 Mn |
| Jun 30, 2024 | 1.67 Mn |
| Mar 31, 2024 | 1.54 Mn |
| Dec 31, 2023 | 1.68 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.67 Mn |
| Mar 31, 2023 | 1.74 Mn |
| Dec 31, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.85 Mn |
| Jun 30, 2022 | 1.81 Mn |
| Mar 31, 2022 | 1.95 Mn |
| Dec 31, 2021 | 1.93 Mn |
| Jun 30, 2021 | 2.89 Mn |
| Mar 31, 2021 | 2.03 Mn |
| Dec 31, 2020 | 1.80 Mn |
| Dec 31, 2019 | 171,473.39 |